Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.685
0.00 (0.00%)
Aug 10, 2025, 8:00 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $240.42 million as of August 12, 2025. Its market cap has decreased by -75.55% in one year.
Market Cap
240.42M
Enterprise Value
126.27M
Revenue
27.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.69
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 240.42M, a decrease of -55.34%. That is a compound annual growth rate of -15.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 238.06M | -26.71% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | 538.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 366.75M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |